약학회지 (YAKHAK HOEJI)

  • 제49권4호
  • /
  • Pages.306-311
  • /
  • 2005
  • /
  • 0377-9556(pISSN)
  • /
  • 2383-9457(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

Ob/ob Mouse에서 비탐-에스의 비 알코올성 지방간 개선 활성

Bitam-S Improves the Non-alcoholic Fatty Liver Disease in C57BL/6J ob/ob Mice

  • 발행 : 2005.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Semisulospira libertine (SL) has been used as a folk medicine for quenching a thirst, hepatic fever and inflammation in oriental countries. Although SL has been anecdotally ascertained to ameliorate the hepatic diseases, there are no sufficient experimental evidences. The purpose of this study was to examine the effect of Bitam-S, in which SL is a main component, on non-alcoholic fatty liver disease manifested in C57BL/6J ob/ob mice. At 6 week old, the ob/ob mice were randomly divided into four groups; control and three treatment groups. The control mice was to receive a regular diet, and the treatment groups were fed a regular diet with either 250mg/kg, 500mg/kg of Bitam-S (BS250 and BS500) or 300mg/kg of metformin (MT300) for a 8-week period. Bitam-S exerted beneficial effects on lipid homeostasis in ob/ob mice that are not necessarily due to its ability to decrease food intake but its specific effects on hepatic lipogenesis related genes (SREBP1a, FAS and SCD-1). The combined effects of Bitam-S to reduce body weight and lipogenic gene expressions, and reduce the deposition of triglyceride in the liver are indicative of a marked improvement in obesity-related non-alcoholic fatty liver disease. Taken together, Bitam-S has potential as a treatment agent for non-alcoholic fatty liver disease and deserves clinical trial in the near future.

키워드

참고문헌

  1. el-Hassen, A. Y., Ibrahim, E. M., al-Mulhim, F. A., Nabhan, A. A. and Chammas, M. Y. : Fatty infiltration of the liver: analysis of prevalence, radiological and clinical findings. Br. J. Radiol. 65, 774 (1992) https://doi.org/10.1259/0007-1285-65-777-774
  2. Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C. and Cristianini, G. : Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysis study. Hepatology 20, 1442 (1994) https://doi.org/10.1002/hep.1840200611
  3. Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G. and Melchionda, N. : Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450 (1999) https://doi.org/10.1016/S0002-9343(99)00271-5
  4. Sheth, S. G., Gordon, F. D. and Chopar, S. : Nonalcoholic steatohepatitis. Ann. Intern. Med. 126, 137 (1997) https://doi.org/10.7326/0003-4819-126-2-199701150-00008
  5. Matteoni, C., Younossi, Z. M. and McCullough, A. : Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 116, 1413 (1999) https://doi.org/10.1016/S0016-5085(99)70506-8
  6. 김일훈 : 신약본초 (전편), 도서출판 인산가, 서울, p. 78 (2002)
  7. Campfield, L. A., Smith, F. J. and Burn, P. : The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks. Horm. Metab. Res. 28, 619 (1996) https://doi.org/10.1055/s-2007-979867
  8. Meglasson, M. D., Wilson, J. M., Yu, J. H., Robinson, D. D., Wyse, B. M. and de Souza, C. J. : Anti hyperglycemic actions of guanidenoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL-6J ob/ ob mice and increases glucose disappearance in rhesus monkeys. J. Pharmacol. Exp. Ther. 266, 1454 (1993)
  9. Uysal, K. T., Wiesbrock. S. M., Marino, M. W. and Hotamisigli, G. S. : Protection from obesity-induced insulin-resistance in mice lacking TNF${\alpha}$ function. Nature 389, 610 (1997) https://doi.org/10.1038/39335
  10. Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. and Diehl, A. M. : Obesity increases sensitivity of endotoxin liver injury: implications for pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94, 2557 (1997)
  11. Chomczynski, P. and Sacchi, N. : Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156 (1987)
  12. 이관식 : 알기 쉬운 간질환, 가림출판사, 서울, p. 44-45 (2005)
  13. Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L. and Brown, M. S. : Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182 (1998) https://doi.org/10.1101/gad.12.20.3182
  14. Shimomura, I., Bashmakow, Y. and Horton, J. D. : Increased nuclear levels of SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274, 30028 (1999) https://doi.org/10.1074/jbc.274.42.30028
  15. Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Rennet, G. and Diehl, A. M. : Mtformin reverses fatty acid disease in obese, leptin-deficient mice. Nature Medicine 6(8), 998 (2000) https://doi.org/10.1038/79697
  16. Matthews, D. R., Hosker, J. P., Rudenky, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. : Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28, 412 (1985) https://doi.org/10.1007/BF00280883